NEW YORK, NY / ACCESSWIRE / August 26, 2019 / Wesfarmers Ltd. (OTCPINK: WF3) will be discussing their earnings results in their 2019 Second Half Earnings to be held on August 26, 2019 at 10:00 PM Eastern Time.

To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/company/C-C19C7EF85A8D7

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company’s profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on the what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 557269

Global Customer Service Leader Names Rainer Diekmann As Managing Director, Europe And Alvaro Garcia as Managing Director, Latin America As Part Of Company’s Newest Senior-Level Appointments

DALLAS, TX / ACCESSWIRE / August 26, 2019 / Reflecting the company’s continuing expansion in the US and key international markets, Continuum Global Solutions LLC (www.continuumgbl.com) has announced several new additions to its senior management team, led by the appointments of Rainer Diekmann as Managing Director, Europe And Alvaro Garcia as Managing Director, Latin America and Caribbean.

Rainer Diekmann

Diekmann takes the helm of Continuum’s European operations bringing 25 years of sales and management expertise to his new role. Prior to joining Continuum, Rainer was Vice President Germany and the European Portfolio Lead for Telecommunications, Media and Utilities at Conduent, Inc. Rainer was also the Founder and Managing Director of Invoco, an outsourced customer care company, and Managing Director of Walter Services. He graduated from University in Wiesbaden, Germany with a degree in economics.

Alvaro Garcia

Garcia joins Continuum Global Solution with over two decades of experience in the customer care industry, most recently serving as the Managing Director of South American Operations for Conduent, Inc. and Xerox. Alvaro also held numerous leadership roles at Entel, a multinational telecommunications firm based in Chile. He brings to his new Continuum leadership position a wealth of expertise with a strong understanding of managing telecommunications and contact centers in various Latin America countries including Argentina, Chile, Colombia, Ecuador, El Salvador, Guatemala, Honduras and Perú. Alvaro holds a Commercial Engineering degree from the Universidad Católica de Chile.

Rochelle Moyer

Also named to the Continuum management team are Ann Harts, who assumes the role of Director of Global Real Estate & Facilities , Rochelle Moyer, who joins the company as Vice President PMO and Compliance; Martii Simpson, who is named Director of Business Solutions; and Michael Dayton who will serve as Vice President of Work Force Management.

Ann Harts

Bringing over 20 years’ experience in site selection, real estate strategy, labor analysis and public incentive advisory, Harts has previously led the global real estate operations for two publicly traded BPO organizations. As a three-time winner of Nearshore America’s Most Influential Executives, she is also an award-winning speaker who has authored numerous articles, and hosted podcasts covering the customer care industry. She was also a co-founder of the LatAm Alliance, and a member of their Board of Directors. She received her bachelor’s degree from Kansas State University and is a graduate of the Economic Development Institute at the University of Oklahoma.

Martii Simpson

Moyer, who will oversee project management, security and special projects as part of her new assignment with Continuum is a seasoned project and program management professional with experience in Lean Six Sigma, process optimization, risk management, operations and strategic planning. Prior to joining Continuum, she served as Implementation Director at Conduent, Inc. where she was responsible for managing a team of project managers. She also held similar program and project manager responsibilities at Xerox. She received her bachelor’s degree from Texas A&M University and her MBA from the University of Rochester Simon School.

Continuum Global Solutions Adds To Management Team

Simpson joins Continuum with over 25 years of experience working in business process outsourcing, customer care and telecommunications. In addition to growing the footprint of the business, she oversees contract administration and requests for proposals. With a strong knowledge of business operation and business development including revenue forecasting, budgeting and margin improvement, she has been responsible for managing high profile, high visibility clients across large multi-national enterprises. Simpson has a BS Mathematics/Actuarial Science from Slippery Rock University and an MBA from Frostburg State University.

Michael Dayton

In his new position with Continuum, Dayton be responsible for the strategic direction and tactical guidance for capacity planning, real-time management, intra-day analysis, forecasting and scheduling at Continuum’s 34 sites around the world. Dayton joins Continuum with more than 25 years of experience in contact center industry workforce management, operations and technology. He previously served as Vice President of Workforce Management for LPL Financial, the largest independent broker-dealer in the United States. Earlier in his career Michael held workforce leadership positions at Accenture, Hyundai Capital, PSCU Financial, Toyota Financial Services, Experian, Adelphia, Airtouch and People Support. Dayton is a member of the Society of Workforce Management Professionals, Workforce Management Software Group, International Call Center Group and Workforce Management Consultant Group. He received a BS in Management from Hayward University.

“As Continuum Global Solutions continues its commitment towards delivering to clients the highest levels of excellence, we are proud to attract senior-level executives that bring to the company unparalleled customer care expertise and outstanding track records of success. Together with our exciting new management team, we look forward to further serving the industry as a trend-setting industry leader,” said Jerry Kinnick, President, President of Continuum Global Solutions.

About Continuum Global Solutions, LLC: Headquartered in Dallas, Continuum Global Solutions “CGS” customer care services and call centers have been embraced by top companies worldwide. The company’s Fortune-500 clients rely on its expertise in customer care management. CGS customer care and call center solutions leverage world class voice, chat, email, and social technologies. Continuum has more than 15,000 employees in major international markets and serves tier-1 clients across multiple industry verticals. More information can be found at www.continuumgbl.com .

About Skyview Capital, LLC: Parent of Continuum Global Solutions, Skyview Capital, LLC is a global private investment firm headquartered in Los Angeles, California, that specializes in the acquisition and management of mission critical enterprises in the areas of technology, telecommunications, business services and niche manufacturing. By leveraging its operational capabilities and financial acumen, Skyview systematically enhances the long-term sustainable value of the businesses it acquires. The Los Angeles Business Journal recently recognized Skyview as one of the top 25 private equity firms in Los Angeles. To date, Skyview has successfully completed over 25 transactions within its target market verticals. For further information, please visit www.skyviewcapital.com.

CONTACT:
Steve Syatt
SSA Public Relations
steve@ssapr.com
(818) 222-4000

SOURCE: SSA Public Relations

ReleaseID: 557466

NEW YORK, NY / ACCESSWIRE / August 26, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

CannTrust Holdings Inc. (NYSE:CTST)
Class Period: November 14, 2018 to July 12, 2019
Lead Plaintiff Deadline: September 9, 2019

According to filed complaints, CannTrust Holdings Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company was growing cannabis in its Pelham greenhouse while applications for regulatory approval were still pending; (2) the Company’s Pelham greenhouse did not comply with certain regulations; (3) as a result, the Company was reasonably likely to face an inventory hold by Health Canada until the Pelham facility becomes compliant with applicable regulations; (4) as a result, the Company’s customers would face shortages and would likely seek product from CannTrust’s competitors; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in CTST: http://www.kleinstocklaw.com/pslra-1/canntrust-holdings-inc-loss-submission-form?id=3186&from=1

Eagle Bancorp, Inc. (NASDAQGS:EGBN)
Class Period: March 2, 2015 to July 17, 2019
Lead Plaintiff Deadline: September 23, 2019

The complaint alleges that during the class period Eagle Bancorp, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Eagle Bancorp’s internal controls and procedures and compliance policies were inadequate; (ii) the foregoing shortcoming created a foreseeable risk of heightened regulatory scrutiny and the need for the Company undertake its own internal investigations; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in EGBN: http://www.kleinstocklaw.com/pslra-1/eagle-bancorp-inc-loss-submission-form?id=3186&from=1

Carbonite, Inc. (NASDAQGM:CARB)
Class Period: February 7, 2019 to July 25, 2019
Lead Plaintiff Deadline: September 30, 2019

Carbonite, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) Carbonite’s Server Backup VM Edition was of poor quality and technologically flawed; (ii) Carbonite was receiving poor reviews and complaints from customers about the Server Backup VM Edition; (iii) the poor quality and technological flaws of the Server Backup VM Edition was acting as a “disruptive” factor throughout the Carbonite salesforce and keeping that sales organization from closing opportunistically on several larger deals during fiscal 2019; and (iv) as a result of the foregoing, Carbonite lacked any reasonable basis for issuing its positive projections and financial forecasts.

Learn about your recoverable losses in CARB: http://www.kleinstocklaw.com/pslra-1/carbonite-inc-loss-submission-form?id=3186&from=1

Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

ReleaseID: 557539

NEW YORK, NY / ACCESSWIRE / August 26, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Karyopharm Therapeutics Inc (NASDAQGS:KPTI)
Class Period: on behalf of shareholders of Karyopharm Therapeutics Inc. who: (1) purchased shares of Karyopharm’s common stock between March 2, 2017 and February 22, 2019, inclusive; (2) purchased Karyopharm shares in or traceable to the Company’s public offering of common stock conducted on or around April 28, 2017; or (3) purchased Karyopharm shares in or traceable to the Company’s public offering of common stock conducted on or around May 7, 2018.
Lead Plaintiff Deadline: September 23, 2019

Karyopharm Therapeutics Inc allegedly made materially false and/or misleading statements and/or failed to disclose that: Throughout the Class Period, the Company continued to tout the commercial prospects for selinexor and consistently described selinexor as having a “predictable and manageable tolerability profile” and a “very nice safety profile,” and assured investors that it was “well tolerated” by patients. Karyopharm also claimed that selinexor had the potential to be used as a new treatment for MM, with limited and manageable side effects. As a result of these misrepresentations, Karyopharm shares traded at artificially inflated prices during the Class Period.

Learn about your recoverable losses in KPTI: http://www.kleinstocklaw.com/pslra-1/karyopharm-therapeutics-inc-loss-submission-form?id=3187&from=1

Just Energy Group Inc. (NYSE:JE)
Class Period: November 9, 2017 to July 23, 2019
Lead Plaintiff Deadline: September 30, 2019

The complaint alleges Just Energy Group Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company experienced customer enrollment and nonpayment issues; (2) as a result, the Company was reasonably likely to incur an impairment charge to its accounts receivable; (3) as a result, the Company lacked adequate internal control over its financial reporting; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in JE: http://www.kleinstocklaw.com/pslra-1/just-energy-group-inc-loss-submission-form?id=3187&from=1

International Flavors & Fragrances Inc. (NYSE:IFF)
Class Period: May 7, 2018 to August 5, 2019
Lead Plaintiff Deadline: October 11, 2019

The complaint alleges that during the class period International Flavors & Fragrances Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) that Frutarom Industries Ltd. (“Frutarom”), which the Company acquired in 2018, had bribed customers in Russia and Ukraine; (2) that senior management at Frutarom were aware of such improper payments; (3) that, as a result, Frutarom’s financial results were materially overstated; (4) that, as a result of the improper payments, the Company was reasonably likely to face regulatory scrutiny; (5) that the Company had not completed adequate due diligence before acquiring Frutarom; (6) that, as a result of the foregoing, the Company was unlikely to achieve purported synergies from the acquisition; and (7) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in IFF: http://www.kleinstocklaw.com/pslra-1/international-flavors-fragrances-inc-loss-submission-form?id=3187&from=1

Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

ReleaseID: 557541

RADNOR, PA / ACCESSWIRE / August 26, 2019 / The law firm of Kessler Topaz Meltzer & Check, LLP reminds Acer Therapeutics, Inc. (NASDAQ:ACER) (“Acer”) investors that a securities fraud class action lawsuit has been filed on behalf of those who purchased or otherwise acquired Acer securities between September 25, 2017 and June 24, 2019, inclusive (the “Class Period”).

REMINDER: Investors who purchased Acer securities during the Class Period may, no later than August 30, 2019, seek to be appointed as a lead plaintiff representative of the class. For additional information or to learn how to participate in this litigation please visit www.ktmc.com/acer-therapeutics-inc-securities-class-action.

According to the complaint, Acer is a pharmaceutical company that focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Acer’s pipeline includes, inter alia, EDSIVO (celiprolol) for the treatment of vascular Ehlers-Danlos syndrome (“vEDS”) in patients with a confirmed type III collagen mutation. vEDS is a rare disease known to cause abnormal fragility in blood vessels, causing aneurysms, arteriovenous fistulas, arterial dissections, and spontaneous vascular ruptures, all of which are potentially life-threatening. In 2004, the French research hospital, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou (“AP-HP”), published data on vEDS patients. Based on AP-HP’s research, investigators began assessing the preventive effect of celiprolol for major cardiovascular events in patients suffering from vEDS “through a multicenter, prospective, randomized, open trial with blinded evaluation of clinical events” (the “Ong Trial”). The Ong Trial was composed of fifty-three participants “randomized at eight centers in France and one center in Belgium.” On December 13, 2016, Acer Therapeutics Inc. (“Private Acer”) – a private Delaware corporation and Acer’s predecessor – issued a press release announcing that it had signed an agreement with AP-HP, which granted exclusive rights to access and use data from the Ong Trial. Private Acer announced it would use this data to support its New Drug Application (“NDA”) for celiprolol in the treatment of vEDS.

The Class Period commences on September 25, 2017, when Acer issued a press release announcing “Positive Results From Pivotal Clinical Trial of EDSIVO” for the treatment of vEDS.

According to the complaint, on June 25, 2019, Acer issued a press release disclosing that the U.S. Food and Drug Administration (“FDA”) rejected Acer’s NDA for EDSIVO. The press release cited the need for an “adequate and well-controlled trial” evaluating EDSIVO’s effectiveness in reducing the risk of clinical events in patients with vEDS. That same day, Reuters published an article titled “FDA declines to approve Acer Therapeutics’ rare genetic disorder treatment.” In discussing the FDA’s rejection of Acer’s NDA, the article noted how “[t]he small group size” of the Ong Trial had “raised questions among experts about the adequacy of the trial results.” Following this news, Acer’s stock price fell $15.16 per share, or 78.63%, to close at $4.12 per share on June 25, 2019.

The complaint alleges that, throughout the Class Period, the defendants made false and/or misleading statements and/or failed to disclose that: (i) Acer lacked sufficient data to support filing EDSIVO’s NDA with the FDA for the treatment of vEDS; (ii) the Ong Trial was an inadequate and ill-controlled clinical study by FDA standards, and was comprised of an insufficiently small group size to support EDSIVO’s NDA; (iii) consequently, the FDA would likely reject EDSIVO’s NDA; and (iv) as a result, Acer’s public statements were materially false and misleading at all relevant times.

Investors who wish to discuss this securities fraud class action lawsuit and their legal options are encouraged to contact Kessler Topaz Meltzer & Check, LLP (James Maro, Jr., Esq. or Adrienne Bell, Esq.) at (844) 887-9500 (toll free) or at info@ktmc.com.

Acer investors may, no later than August 30, 2019, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation. In order to be appointed as a lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.

Kessler Topaz Meltzer & Check prosecutes class actions in state and federal courts throughout the country involving securities fraud, breaches of fiduciary duties and other violations of state and federal law. Kessler Topaz Meltzer & Check is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world. The firm represents investors, consumers and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars). The complaint in this action was not filed by Kessler Topaz Meltzer & Check. For more information about Kessler Topaz Meltzer & Check, please visit www.ktmc.com.

CONTACT:
Kessler Topaz Meltzer & Check, LLP
James Maro, Jr., Esq.
Adrienne Bell, Esq.
280 King of Prussia Road
Radnor, PA 19087
(844) 887-9500 (toll free)
(610) 667-7706
info@ktmc.com

SOURCE: Kessler Topaz Meltzer & Check, LLP

ReleaseID: 557422

RADNOR, PA / ACCESSWIRE / August 26, 2019 / The law firm of Kessler Topaz Meltzer & Check, LLP reminds CannTrust Holdings Inc. (NYSE:CTST) (“CannTrust”) investors that a securities fraud class action lawsuit has been filed on behalf of those who purchased or otherwise acquired CannTrust securities between November 14, 2018 and July 5, 2019, inclusive (the “Class Period”).

Important Deadline Reminder: Investors who purchased or otherwise acquired CannTrust securities during the Class Period may, no later than September 9, 2019, seek to be appointed as a lead plaintiff representative of the class. For additional information or to learn how to participate in this litigation please visit www.ktmc.com/canntrust-holdings-inc-securities-class-action.

According to the complaint, CannTrust is a licensed producer and distributor of medical and recreational cannabis.

The Class Period commences on November 14, 2018, when CannTrust announced its third quarter 2018 financial results in a press release.

According to the complaint, on July 8, 2019, CannTrust disclosed that its greenhouse facility in Pelham, Ontario is non-compliant with certain regulations, and that CannTrust was growing cannabis in unlicensed rooms between October 2018 and March 2019.

The complaint alleges that, throughout the Class Period, the defendants failed to disclose to investors that: (1) CannTrust was growing cannabis in its Pelham greenhouse while applications for regulatory approval were still pending; (2) CannTrust’s Pelham greenhouse did not comply with certain regulations; (3) as a result, CannTrust was reasonably likely to face an inventory hold by Health Canada until the Pelham facility becomes compliant with applicable regulations; (4) as a result, CannTrust’s customers would face shortages and would likely seek product from CannTrust’s competitors; and (5) as a result of the foregoing, the defendants’ positive statements about CannTrust’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.

If you wish to discuss this securities fraud class action lawsuit or have any questions concerning this notice or your rights or interests with respect to this litigation, please contact Kessler Topaz Meltzer & Check (James Maro, Jr., Esq. or Adrienne Bell, Esq.) at (844) 887-9500 (toll free) or (610) 667-7706, or via e-mail at info@ktmc.com.

CannTrust investors may, no later than September 9, 2019, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation. In order to be appointed as a lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.

Kessler Topaz Meltzer & Check prosecutes class actions in state and federal courts throughout the country involving securities fraud, breaches of fiduciary duties and other violations of state and federal law. Kessler Topaz Meltzer & Check is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world. The firm represents investors, consumers and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars). The complaint in this action was not filed by Kessler Topaz Meltzer & Check. For more information about Kessler Topaz Meltzer & Check, please visit www.ktmc.com.

CONTACT:

Kessler Topaz Meltzer & Check, LLP
James Maro, Jr., Esq.
Adrienne Bell, Esq.
280 King of Prussia Road
Radnor, PA 19087
(844) 887-9500 (toll free)
(610) 667-7706
info@ktmc.com

SOURCE: Kessler Topaz Meltzer & Check, LLP

ReleaseID: 557418

LOS ANGELES, CA / ACCESSWIRE / August 26, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Just Energy Group Inc. (“Just Energy” or “the Company”) (NYSE:JE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities between November 9, 2017 and July 23, 2019, inclusive (the ”Class Period”), are encouraged to contact the firm before September 30, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Just Energy suffered from both customer enrollment and nonpayment problems. The problems make it likely that the Company would be forced into an impairment charge to its accounts receivable. The Company also failed to maintain adequate internal controls over financial reporting. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Just Energy, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.
310-301-3335
Cell: 424-303-1964
info@schallfirm.com
www.schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 557535

LOS ANGELES, CA / ACCESSWIRE / August 26, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of International Flavors & Fragrances Inc. (“International Flavors” or “the Company”) (NYSE:IFF) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. International Flavors announced its second quarter 2019 financials on August 5, 2019. The Company lowered its guidance for fiscal year 2019, setting earnings per share expectations at $4.85 to $5.05 per share on annual revenue of $5.15 billion to $5.25 billion. These figures were revised downwards from $4.90 to $5.10 EPS on $5.2 billion to $5.3 billion in revenue. International Flavors also admitted that it had initiated an investigation of improper payments made by its Israeli subsidiary, “operating principally in Russia and Ukraine . . . to representatives of a number of customers.”

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.
310-301-3335
Cell: 424-303-1964
info@schallfirm.com
www.schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 557533

LOS ANGELES, CA / ACCESSWIRE / August 26, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Eagle Bancorp, Inc. (“Eagle” or “the Company”) (NASDAQ:EGBN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s shares between March 2, 2015 and July 17, 2019, inclusive (the ”Class Period”), are encouraged to contact the firm before September 23, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Eagle failed to maintain adequate internal controls and compliance policies. This failure was likely to result in the need for internal investigations by the Company and created a risk of heightened regulatory scrutiny. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Eagle, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com
Brian Schall, Esq.,
Rina Restaino, Esq.,
www.schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 557532

LOS ANGELES, CA / ACCESSWIRE / August 26, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Curaleaf Holdings, Inc. (“Curaleaf”or “the Company”) (OTCQX:CURLF) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. The FDA sent a warning letter to Curaleaf on July 22, 2019. The FDA letter stated that the Company was selling several CBD products on its website that were “misbranded drugs,” a violation of the Federal Food, Drug, and Cosmetic Act. Based on this news, shares of Curaleaf fell more than 7% on July 23, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.
310-301-3335
Cell: 424-303-1964
info@schallfirm.com
www.schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 557531